Nigra-Subthalamic Dopaminergic Circuitry Modulates and Represents Distinct Pain Modality in Physiological and Pain States in Mice
- Adv Sci (Weinh). 2026 Jul;13(37):e19913. doi: 10.1002/advs.202519913.
- 1. Jiangsu Province Key Laboratory of Anesthesiology School of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- 2. Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, Xuzhou Medical University, Xuzhou, Jiangsu, China.
- 3. Department of Anesthesiology, Xuzhou Central Hospital, Xuzhou, Jiangsu, China.
- 4. Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
- 5. Department of Neurology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
- 6. Key Laboratory of Chemical Safety and Health, National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China.
- 7. Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc) degenerate in Parkinson's disease (PD). Although pain is a common non-motor symptom in PD, it remains unclear whether and how degeneration of SNc DA neurons contributes to hyperalgesia. In the present study, we revealed a nigro-subthalamic DA circuit, composed of a subset of SNc DA neurons, the SNc DA projection to the subthalamic nucleus (STN), and the downstream STN neurons. These components regulate mechanical, but not thermal, pain threshold on the contralateral side, exhibiting distinct responses to mechanical and thermal stimuli which varied in neuropathic pain and Parkinsonian mice. D2-, but not D1-like, dopamine receptors in the STN were involved in these processes, and their activation mitigated mechanical hyperalgesia in both neuropathic pain and Parkinsonian mice. The GABAergic neurons in the substantia nigra pars reticulata (SNr) responded to pain stimulation and facilitated pain responses in SNc DA neurons. Thus, the SNrGABA-SNcDA-STN pathway is involved in the modulation and processing of pain in both physiological and chronic pain states and may be a potential therapeutic target for both neuropathic and Parkinsonian pain.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Neurological Disease
-
-
target: Dopamine ReceptorResearch Areas: Neurological Disease
-
target: Dopamine ReceptorResearch Areas: Neurological Disease
-
target: iGluRResearch Areas: Neurological Disease
-
Research Areas: Neurological Disease
-
target: Dopamine ReceptorResearch Areas: Neurological Disease